J. G. Ribot

Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

Alexandra W. van den Belt‐Dusebout, Ronald de Wit, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2007 · 459 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Roles of Radiation Dose and Chemotherapy in the Etiology of Stomach Cancer as a Second Malignancy

Alexandra W. van den Belt‐Dusebout, Berthe M.P. Aleman, Gijs Besseling et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 98 citations

Medicine, Oncology, Radiation Oncology +16

Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time

Wilfried De Neve, Marnix L.M. Lybeert, C. Goor et al. · Radiotherapy and Oncology · 1995 · 84 citations

Medicine, Oncology, Urology +10

On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975–2004: a long-term population-based study in southeastern Netherlands

Marieke W.J. Louwman, Adri C. Voogd, J.A.A.M. van Dijck et al. · Cancer Causes & Control · 2007 · 83 citations

Medicine, Oncology, Breast Oncology +13

Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: definite but limited influence on relapse-free survival and survival

Marnix L.M. Lybeert, Hendrik Martun, Wilfried De Neve et al. · International Journal of Radiation Oncology*Biology*Physics · 1992 · 64 citations · Full text

Medicine, Oncology, Surgery +16